Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, PetVivo Holdings's Enterprise Value is $14.46 Mil.
PetVivo Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-10.63 Mil. Therefore, PetVivo Holdings's EV-to-EBIT ratio for today is -1.36.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, PetVivo Holdings's Enterprise Value is $14.46 Mil.
PetVivo Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-10.51 Mil. Therefore, PetVivo Holdings's EV-to-EBITDA ratio for today is -1.38.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, PetVivo Holdings's Enterprise Value is $14.46 Mil.
PetVivo Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $1.05 Mil. Therefore, PetVivo Holdings's EV-to-Revenue ratio for today is 13.82.
PetVivo Holdings Enterprise Value Historical Data
The historical data trend for PetVivo Holdings's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of PetVivo Holdings's Enterprise Value
For the Medical Devices subindustry, PetVivo Holdings's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PetVivo Holdings's Enterprise Value Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, PetVivo Holdings's Enterprise Value distribution charts can be found below:
* The bar in red indicates where PetVivo Holdings's Enterprise Value falls into.
PetVivo Holdings Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
PetVivo Holdings's Enterprise Value for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PetVivo Holdings (OTCPK:PETV) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
PetVivo Holdings's current Enterprise Value is $14.46 Mil.
PetVivo Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-10.63 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
PetVivo Holdings's current Enterprise Value is $14.46 Mil.
PetVivo Holdings's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-10.51 Mil.
PetVivo Holdings's current Enterprise Value is $14.46 Mil.
PetVivo Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.05 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PetVivo Holdings Enterprise Value Related Terms
Thank you for viewing the detailed overview of PetVivo Holdings's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
PetVivo Holdings (PetVivo Holdings) Business Description
PetVivo Holdings Inc is an emerging biomedical device company. The group is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for companion animals. A key strategy of the company is to leverage human therapies for the treatment of companion animals cost-effectively and in a timely manner. The accelerated timeline to revenues for veterinary medical devices is a key component of this strategy, which enter the market much earlier than pharmaceuticals and biologics. The product pipeline includes approximately seventeen products intended to treat animals and people. Its patent protection extends to biomaterials, products, production processes, and methods of use provided by the company's portfolio of nineteen patents.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PETV has been successfully added to your 